Medical Research
(H81)
990 on File
CHINA AIDS FUND INC
Financial strength (30%)
48/100
Reliability (20%)
55/100
Effectiveness (25%)
48/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$222K
Total Revenue
$243K
Total Expenses
$576K
Net Assets
2
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
31.5%
Fundraising Efficiency
N/A
Operating Reserve
28.50x
Liability-to-Asset
0.9%
Revenue Diversification
90.3%
Executive Compensation
$80K
Compared with Peers
FY 2024
Compared with 726 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
31.5% | 84.5% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
33.9% | 11.4% |
P10P90
|
Bottom quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
34.6% | 0.0% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
28.5 mo | 13.4 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.9% | 0.4% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
90.3% | 93.3% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
-286.5% | 9.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
325.4% | 8.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-9.2% | 1.8% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $222K | $243K | $576K | 31.5% | 2 |
| 2023 | $-119,009 | $57K | $523K | 46.1% | 2 |
| 2022 | $38K | $23K | $456K | 23.0% | 1 |
| 2021 | $61K | $101K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.